List view / Grid view
25 September 2018 | By Mike Stones
The new hub is designed to speed the response to deadly pandemics by improving the development and manufacturing of vaccines – particularly in low- and middle-income countries...
4 July 2018 | By European Pharmaceutical Review
Novel regimen enables physicians to fully dose up to two months of Aristada treatment on day one...
4 July 2018 | By European Pharmaceutical Review
Evidence suggests the human papillomavirus plays a role in the development of some types of this skin cancer...
2 July 2018 | By SCIEX
Different modalities of monoclonal antibodies are pushing the limits of characterization by MS: new critical quality attributes need to be carefully monitored from developability in early phases and then during process development and clinical phases...
22 June 2018 | By European Pharmaceutical Review
A study has found a novel mechanism underlying stable, durable blood sugar control...
15 June 2018 | By European Pharmaceutical Review
A tricked-out cholera vaccine starts protecting against the deadly disease within a day, experiments in rabbits suggest.
13 June 2018 | By European Pharmaceutical Review
Researchers have identified exterior proteins on the bacteria that could serve as vaccine targets for syphilis.
11 June 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Results from a pivotal trial of a new HIV therapy, show that PRO 140 is an effective, long-acting therapeutic for previously treated HIV-1 infected patients...
23 May 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Two new studies of patients with difficult-to-control asthma show that the eczema drug dupilumab alleviates asthma symptoms and improves patients' ability to breathe better than standard therapies...
22 May 2018 | By European Pharmaceutical Review
Nanoparticles could offer a new way to help eradicate the disease worldwide...
15 May 2018 | By European Pharmaceutical Review
By engineering a special molecule to track certain immune cells in the body, scientists have invented a litmus test for the effectiveness of a newly devised cancer therapy...
14 May 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Researchers synthesized self-assembling peptide amphile nanofibers that targeted areas of plaque and could be delivered by intravenous injection...
11 May 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Fast Track program is designed to facilitate development and expedite review of therapies and vaccines to address unmet health needs...
9 May 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
A Phase 2 clinical trial of an investigational universal influenza vaccine intended to protect against multiple strains of the virus has begun in the United States...
2 May 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
New research could serve as the stepping-stone in constructing vaccines with a greater likelihood of finding and attacking...
Follow: